Drawing for OTSUKA

USPTO serial 99638505

OTSUKA

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
PILATO, DARREN ANTHONY
Law office
TMO LAW OFFICE 125

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with OTSUKA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kazuyo Morita

Kazuyo Morita Holland & Hart LLPP.O. Box 8749Attn: Trademark DocketingDenver, CO 80201

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of mobile applications for supporting treatment experience and pharmaceutical management and assistance; downloadable software in the nature of a mobile application for wellness and general health support, including initiatives related to women’s health and mindfulness that are not classified as pharmaceutical, prescription digital therapeutics, or medical device software; downloadable software in the nature of a mobile application for the development, deployment, and operation of patient-directed software in the field of prescription digital therapeutics and treatment support; downloadable software in the nature of a mobile application for providing counseling and prescription digital therapeutics that utilize digital health technologies to treat and manage medical conditions and employ cognitive behavioral therapy, self-monitoring, and other evidence-based treatments; electronic and optical communications instruments and components, namely, digital transmitters and receivers for use in transmitting and receiving data; downloadable computer programs for use in collecting, managing, analyzing, storing, sharing, comparing, and reporting medical information, patient records, and patient dataPARTIALLY PAID—
035Providing business information in the medical field, namely, providing reports via a SaaS platform and a mobile application for evaluating and measuring patient feedback across healthcare allowing healthcare providers to understand a patient's experience and eliminate barriers to healthcare; providing business information and consultation services related to wellness and general health initiatives, including women’s health programs and mindfulness support, to help organizations understand, manage, and improve user experience; providing business information, namely, providing data to help pharmaceutical professionals and organizations understand, manage, measure and improve patient experience and gain feedback from public and private sources; business consultation services, namely, consultation to help pharmaceutical professionals and organizations understand, manage, measure and improve the patient experience and gain feedback from public and private sources; business data analysis services to help pharmaceutical professionals and organizations understand, manage, measure and improve the customer and patient experience and gain feedback from public and private sources; hospital management analytics services; hospital management consulting services; hospital accounting services; hospital management data analytics services; temporary personnel services; management of telephone call centers for others; retail store services featuring computersPARTIALLY PAID—
042Consulting services in the fields of pharmaceutical research and development; consulting services and software development for wellness and general health support, including women’s health and mindfulness initiatives; consulting services in the field of pharmaceutical research and development and diagnostic research and development; database design and development of digital software platforms for use in pharmaceutical management and assistance; scientific and technological services, namely, research and design in the field of digital medicine systems used to integrate patient-reported data with computer networking systems, data centers, patients and healthcare providers to support clinician decision-making; providing an interactive website featuring technology that enables data transmission, reception and analysis for the purpose of patient access and administration of pharmaceuticals; software as a service (SaaS) featuring software for gathering, analyzing and processing patient information data for the purpose of helping pharmaceutical companies and organizations understand, manage, measure and improve patient experience and gain feedback from public and private sources; software development in the fields of healthcare, therapeutics, and pharmaceuticals; software as a service (SaaS) featuring software for monitoring, reporting on, and analyzing the use of therapeutics and pharmaceuticals; software as a service (SaaS) featuring software for pharmaceutical professionals and organizations to communicate regarding healthcare and the use of therapeutics and pharmaceuticals; providing temporary use of non-downloadable computer software to facilitate the matching of users with insurance and financial products in the pharmaceutical industry; research and development of prescription digital therapeutics and treatment support via a software application allowing patients to employ cognitive behavioral therapy, self-monitoring, and other evidence-based treatments; providing temporary use of non-downloadable computer programs for use in collecting, managing, analyzing, storing, sharing, and comparing medical information, patient records, and patient data; technology consulting services for digital transformation; consulting in the field of IT project managementPARTIALLY PAID—
044Providing medical information, consultancy and advisory services for supporting clinician determined decision making for medical diagnostic and medical treatment purposes; providing wellness and general health information, consultancy and advisory services, including women’s health and mindfulness programs; maintaining patient medical records and files; providing a database for use in collecting, managing, analyzing, storing, sharing, and comparing medical information, patient records, and patient data; medical data analysis for medical diagnostic and medical treatment purposes; patient medical data analysis for medical diagnostic and medical treatment purposes; healthcare consultancy services; healthcare analytics services in the nature of providing an internet-based database of patient medical information, patient medical records, and patient medical data for medical diagnostic and medical treatment purposes; medical reporting services, namely, compilation of medical reportsPARTIALLY PAID—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 1, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 16, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2026DOCKASSIGNED TO EXAMINER—
Jun 11, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 6, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance